title: Targeting HSV amplicon vectors.
abstract: Several techniques have been developed to deliver DNA directly into mammalian cells, spanning in difficulty from simple mixing procedures to complex systems requiring expensive equipment. Viral vectors have proven able to deliver genes into mammalian cells with high efficiency and low toxicity. In particular, herpes simplex virus type-1 (HSV-1) amplicon vectors are well suited for gene transfer studies as they can infect many cell types, both non-dividing and dividing, have a large transgene capacity and are easy to manipulate. For some applications, it may be desirable to target gene delivery to specific cell populations or to transduce normally non-susceptible cells. This can be achieved by modifying one or more of the glycoproteins found in the viral envelope. Glycoprotein C (gC) has a well-characterized heparan sulfate binding domain (HSBD) necessary for HSV binding to cells. Replacing this region with unique ligands can result in less efficient binding to natural target cells and increase binding to cells which express receptors for these ligands. A method to retarget amplicon vectors by replacing gC HSBD with a model ligand, the hexameric histidine-tag, is described, as well as means to evaluate the binding of modified vector as compared to wild-type virus to cells with or without the appropriate receptor, in this case, a his-tag pseudo-receptor. This protocol demonstrates increased binding of modified virus to receptor-positive cells (at levels greater than wild-type) with no loss of infectivity. Retargeted vectors can provide an additional tool for increasing the efficiency of gene delivery to specific cell types.
authors.affiliation: Departments of Neurology and Radiology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, Charlestown, MA 02129, USA.
authors.forename: Paola
authors.initials: P
authors.lastname: Grandi
authors.forename: Matthew
authors.initials: M
authors.lastname: Spear
authors.forename: Xandra O
authors.initials: XO
authors.lastname: Breakefield
authors.forename: Samuel
authors.initials: S
authors.lastname: Wang
mesh_terms: D000818:Animals; D002460:Cell Line; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000235:genetics*; D000882:Haplorhini; D018259:Herpesvirus 1, Human / Q000235:genetics*; D006801:Humans; D010957:Plasmids / Q000235:genetics*; D017434:Protein Structure, Tertiary / Q000235:genetics; D014162:Transfection / Q000379:methods*; D014759:Viral Envelope Proteins / Q000235:genetics*; D014771:Virion / Q000378:metabolism
chemical_list: D014759:Viral Envelope Proteins; C038535:glycoprotein gC, herpes simplex virus type 1